- Home
- IMNN vs NCRA Comparison
IMNN vs NCRA Comparison
Compare IMNN & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- NCRA
- Stock Information
- Founded
- IMNN 1982
- NCRA 2002
- Country
- IMNN United States
- NCRA Taiwan
- Employees
- IMNN N/A
- NCRA N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- IMNN Health Care
- NCRA Consumer Staples
- Exchange
- IMNN Nasdaq
- NCRA Nasdaq
- Market Cap
- IMNN 12.1M
- NCRA 13.9M
- IPO Year
- IMNN 1985
- NCRA N/A
- Fundamental
- Price
- IMNN $0.60
- NCRA $1.00
- Analyst Decision
- IMNN Strong Buy
- NCRA
- Analyst Count
- IMNN 2
- NCRA 0
- Target Price
- IMNN $15.50
- NCRA N/A
- AVG Volume (30 Days)
- IMNN 237.6K
- NCRA 83.7K
- Earning Date
- IMNN 05-12-2025
- NCRA 05-06-2025
- Dividend Yield
- IMNN N/A
- NCRA N/A
- EPS Growth
- IMNN N/A
- NCRA N/A
- EPS
- IMNN N/A
- NCRA N/A
- Revenue
- IMNN N/A
- NCRA $17,013,132.00
- Revenue This Year
- IMNN N/A
- NCRA N/A
- Revenue Next Year
- IMNN N/A
- NCRA N/A
- P/E Ratio
- IMNN N/A
- NCRA N/A
- Revenue Growth
- IMNN N/A
- NCRA N/A
- 52 Week Low
- IMNN $0.64
- NCRA $0.70
- 52 Week High
- IMNN $3.65
- NCRA $2.09
- Technical
- Relative Strength Index (RSI)
- IMNN 24.71
- NCRA 53.09
- Support Level
- IMNN $0.60
- NCRA $0.87
- Resistance Level
- IMNN $1.08
- NCRA $1.03
- Average True Range (ATR)
- IMNN 0.08
- NCRA 0.12
- MACD
- IMNN -0.02
- NCRA 0.01
- Stochastic Oscillator
- IMNN 3.12
- NCRA 52.38
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.